- Home
- RLAY vs PRTH Comparison
RLAY vs PRTH Comparison
Compare RLAY & PRTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- PRTH
- Stock Information
- Founded
- RLAY 2015
- PRTH 2005
- Country
- RLAY United States
- PRTH United States
- Employees
- RLAY N/A
- PRTH N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- PRTH EDP Services
- Sector
- RLAY Health Care
- PRTH Technology
- Exchange
- RLAY Nasdaq
- PRTH Nasdaq
- Market Cap
- RLAY 619.0M
- PRTH 550.3M
- IPO Year
- RLAY 2020
- PRTH N/A
- Fundamental
- Price
- RLAY $4.12
- PRTH $7.69
- Analyst Decision
- RLAY Strong Buy
- PRTH Strong Buy
- Analyst Count
- RLAY 13
- PRTH 4
- Target Price
- RLAY $18.00
- PRTH $12.25
- AVG Volume (30 Days)
- RLAY 1.5M
- PRTH 520.7K
- Earning Date
- RLAY 11-05-2025
- PRTH 11-06-2025
- Dividend Yield
- RLAY N/A
- PRTH N/A
- EPS Growth
- RLAY N/A
- PRTH N/A
- EPS
- RLAY N/A
- PRTH 0.26
- Revenue
- RLAY $8,355,000.00
- PRTH $918,558,000.00
- Revenue This Year
- RLAY $31.55
- PRTH $12.76
- Revenue Next Year
- RLAY N/A
- PRTH $10.49
- P/E Ratio
- RLAY N/A
- PRTH $29.04
- Revenue Growth
- RLAY N/A
- PRTH 12.86
- 52 Week Low
- RLAY $1.78
- PRTH $5.01
- 52 Week High
- RLAY $10.72
- PRTH $12.47
- Technical
- Relative Strength Index (RSI)
- RLAY 65.83
- PRTH 46.31
- Support Level
- RLAY $3.52
- PRTH $8.10
- Resistance Level
- RLAY $4.26
- PRTH $8.59
- Average True Range (ATR)
- RLAY 0.22
- PRTH 0.35
- MACD
- RLAY 0.07
- PRTH -0.04
- Stochastic Oscillator
- RLAY 85.26
- PRTH 10.85
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About PRTH Priority Technology Holdings Inc.
Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium business enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments, and Enterprise Payments. SMB Payments segment which generates the majority of revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging Priority's proprietary software platform, distributed through ISO; the B2B Payments segment provides AP automation solutions to corporations, software partners, & industry FIs: and Enterprise Payments segment provides embedded payment & treasury solutions to enterprise customers to modernize legacy platforms & accelerate software partners' strategies to monetize payments.